The complexity of renal anemia—stemming from multiple factors including iron deficiency, inflammation, and reduced erythropoietin production—underscores the critical role of data in shaping the market’s therapeutic approach. The transition to precision medicine is entirely dependent on acquiring and analyzing large-scale, high-quality clinical and epidemiological data. This...